Ribozymes: A modern tool in medicine

Asad U. Khan; Sunil K. LAL

doi:10.1007/bf02256107

journal article Sep 01, 2003

Ribozymes: A modern tool in medicine

Asad U. Khan

Sunil K. LAL

Journal of Biomedical Science Vol. 10 No. 5 pp. 457-467 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/bf02256107

Topics

No keywords indexed for this article. Browse by subject →

References

66

[1]

Ribozymes: Killing the Messenger

Marcia Barinaga

Science 1993 10.1126/science.8248799

[2]

Belfort M. Phage T4 introns: Self-splicing and mobility. Annu Rev Genet 24:363–385;1990. 10.1146/annurev.ge.24.120190.002051

[3]

Bramlage B, Luzi E, Eckstein F. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: Site selection and inhibition in cell culture. Nucleic Acids Res 28:4059–4067;2000. 10.1093/nar/28.21.4059

[4]

Cech TR. Structural biology. The ribosome is a ribozyme. Science 289:878–879;2000. 10.1126/science.289.5481.878

[5]

Cech TR, Herschlag D. Group I ribozyme: Structure recognition catalysis strategies and comparative mechanistic analysis; in Eckstein F, Lilley DMJ (eds): Nucleic Acid and Molecular Biology. New York, Springer, Catalytic RNA, vol 10, pp 1–17, 1996.

[6]

Chen Y, Li X, Gegenheimer P. Ribonuclease P catalysis requires Mg2+ coordinated to the pro-RP oxygen of the scissile bond. Biochemistry 36:2425–2438;1997. 10.1021/bi9620464

[7]

Choo Y, Sanchez-Garcia I, Klug A. In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature 372:642–645;1994. 10.1038/372642a0

[8]

Cobaleda C, Perez-Losada J, Sanchez-Garcia I. Chromosomal abnormalities and tumor development: From gene to therapeutic mechanisms. Bioassay 20:922;1998. 10.1002/(sici)1521-1878(199811)20:11<922::aid-bies7>3.0.co;2-o

[9]

Cobeleda C, Sanchez-Garcia I. In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: A novel approach for cancer treatment. Blood 95:731–737;2000. 10.1182/blood.v95.3.731.003k28_731_737

[10]

Cogoni C, Macino G. Post-transcriptional gene silencing across kingdoms. Curr Opin Genet Dev 10:638–643;2000. 10.1016/s0959-437x(00)00134-9

[11]

Collins RA. The Neurospora varkud satellite ribozyme. Biochem Soc Trans 30:1122–1126;2001. 10.1042/bst0301122

[12]

Collins CA, Guthrie C. The question remains: Is the spliceosome a ribozyme? Nat Struct Biol 10:850–854;2000.

[13]

Collins RA, Saville BJ. Independent transfer of mitochondrial chromosomes and plasmids during unstable vegetative fusion in Neurospora. Nature 345:177–179;1990. 10.1038/345177a0

[14]

Cornberg M, Wedemeyer H, Manns MP. Hepatitis C: Therapeutic perspectives. Forum 11:154–162;2001.

[15]

Dropulic B, Jeang KT. Gene therapy for human immunodeficiency virus infection: Genetic antiviral strategies and targets for intervention. Hum Gene Ther 5:927–939;1994. 10.1089/hum.1994.5.8-927

[16]

Dropulic B, Lin NH, Martin MA, Jeang KT. Functional characterization of a U5 ribozyme: Intracellular suppression of human immunodeficiency virus type 1 expression. J Virol 66:1432–1441;1992. 10.1128/jvi.66.3.1432-1441.1992

[17]

Earnshaw DJ, Gait MJ. Hairpin ribozyme cleavage catalyzed by aminoglycoside antibiotics and the polyamine spermine in the absence of metal ions. Nucleic Acid Res 26:5551–5561;1998. 10.1093/nar/26.24.5551

[18]

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Sayda M. Elbashir, Jens Harborth, Winfried Lendeckel et al.

Nature 2001 10.1038/35078107

[19]

Famulok M, Mayer G. Aptamers as tools in molecular biology and immunology. Curr Top Microbiol Immunol 243:123–136;1999.

[20]

Famulok M, Mayer G, Blind M. Nucleic acid aptamers-from selection in vitro to applications in vivo. Acc Chem Res 33:591–599;2000. 10.1021/ar960167q

[21]

Feere D, Amare AR, Zhou K, Daudna JA. Crystal structure of hepatitis delta virus ribozyme. Nature 395:567–574;1998. 10.1038/26912

[22]

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Andrew Fire, SiQun Xu, Mary K. Montgomery et al.

Nature 1998 10.1038/35888

[23]

Forster AC, Altman S. External guide sequence for and RNA enzyme. Science 249:783–786;1990. 10.1126/science.1697102

[24]

Foster AC, Sympson RH. Self cleavage of virusoid RNA is performed by the proposed 55-nucleotide active site. Cell 50:9–16;1987. 10.1016/0092-8674(87)90657-x

[25]

Giordano V, Jin DY, Rekosh D, Jeang KT. Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol. Virology 267:174–184;2000. 10.1006/viro.1999.0112

[26]

Hampel A, Tritz R, Hicks M, Cruz P. Hairpin catalytic RNA. Nucleic Acid Res 18:299–304;1990. 10.1093/nar/18.2.299

[27]

Hegg L, Afedor MJ. Kinetic and thermodynamics of intermolecular catalysis by hairpin ribozymes. Biochemistry 34:15813–15828;1995. 10.1021/bi00048a027

[28]

Hsieh SY, Taylor J. Delta virus is a vector, for the delivery of biologically active RNA: Possibly a ribozyme specific for chronic hepatitis B virus infection. Adv Exp Med Biol 312:125–128;1992. 10.1007/978-1-4615-3462-4_12

[29]

Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Modulation of HIV-1 replication by RNA interference. Nature 418:435–438;2002. 10.1038/nature00896

[30]

Khan AU, Ahmad M, Lal SK. Restoration of mRNA splicing by a second-site intragenic supressor in the T4 ribonucleotide reductase (small subunit) self-splicing intron. Biochem Biophys Res Comm 268:359–364;2000. 10.1006/bbrc.2000.2144

[31]

Khan AU, Lal SK, Ahmad M. Isolation and characterization of EMS induced splicing defective point mutations within the intron of the nrdB gene of bacteriophage T4. Biochem Biophys Res Comm 242:10–15;1998. 10.1006/bbrc.1997.7553

[32]

Khan AU, Lal SK. Ribozyme: A structure and potential applications in medicine. Med Sci Res 27:507–512;1999.

[33]

Khan AU, Lal SK. The white halo plaque phenotype of bacteriophage T4: Its uses and applications in screening and mapping of splicing-defective mutants. J Biochem Mol Biol Biophys 5:237–242;2001.

[34]

Kirsebom LA. RNase P RNA-mediated catalysis. Biochem Soc Trans 30:1153–1158;2001. 10.1042/bst0301153

[35]

Koizumi M, Ozawa Y, Yagi R, Nishigaki T, Keneko M, Oka SI, Kimura S, Iwamato A, Komatso Y, Ohtsuka E. Design and anti-HIV-I activity of hammerhead and hairpin ribozymes containing a stable loop. Nucl Nucl 17:207–218;1998. 10.1080/07328319808005170

[36]

Koizumi M, Ozawa Y, Yagi R, Nishigaki T, Kamatsua Y, Ohtsuaka E. Design and anti-HIV-1 activity of ribozymes that cleave HIV-1 LTR. Nucleic Acids Symp Ser 34:125–126;1995.

[37]

Koizumi M, Soukup GA, Kerr JN, Breaker RR. Allosteric selection of ribozymes that respond to the second messengers cGMP and cAMP. Nat Struct Biol 6:1062–71;1999. 10.1038/14947

[38]

Kuo MY-P, Sharmeen L, Dinter-Gottlieb G, Taylor J. Characterization of self-cleavage RNA sequences on the genome and anti-genome of human hepatitis delta virus. J Virol 62:4439–4444;1988. 10.1128/jvi.62.12.4439-4444.1988

[39]

Kurz M, Breaker RR. In vitro selection of nucleic acid enzymes. Curr Top Microbiol Immunol 243:137–158;1999.

[40]

Kwon HY, Lal SK, Hall DH. A novel approach for isolation and mapping of second-site revertants of intron mutations in a ribonucleotide reductase encoding gene (nrdB) of bacteriophage T4 using the white halo plaque phenotype. Nucl Nucl 14:1811–1821;1995. 10.1080/15257779508009759

[41]

Lal SK, Hall DH. A novel approach for isolation and mapping of intron mutations in a ribonucleotide reductase encoding gene (nrdB) of bacteriophage T4 using the white halo plaque phenotype. Biochem Biophys Res Commun 196:943–949;1993. 10.1006/bbrc.1993.2340

[42]

Lal SK, Hall DH. Functional and sequence analysis of splicing defective nrdB mutants of bacteriophage T4 reveal new bases and a new sub-domain required for group I intron self-splicing. Biochim Biophys Acta 1350:89–97;1997. 10.1016/s0167-4781(96)00151-0

[43]

Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P, Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 20:500–505;2002. 10.1038/nbt0502-500

[44]

Liu F, Altman S. Requirements for cleavage by a modified RNase P of a small model substrate. Nucleic Acid Res 24:2690;1996. 10.1093/nar/24.14.2690

[45]

Macejak DG, Jensen KL, Jamison SF, Domenico K, Roberts EC, Chaudhary N, von Carlowitz I, Bellon L, Tong MJ, Conrad A, Pavco PA, Blatt LM. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology 31:769–776;2000. 10.1002/hep.510310331

[46]

Macejak DG, Jensen KL, Pavco PA, Phipps KM, Heinz BA, Colacino JM, Blatt LM. Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA. J Viral Hepat 8:400–405;2001. 10.1046/j.1365-2893.2001.00321.x

[47]

Muotri AR, da Veiga Pereira L, dos Reis Vasques L, Menck CF. Ribozyme and anti-gene therapy: How a catalytic RNA can be used to inhibit gene function. Gene 37:303–310;1999. 10.1016/s0378-1119(99)00334-0

[48]

Murray JB, Seyhan AA, Walter NG, Burke JM, Scott WG. The hammerhead, hairpin and VS ribozyme are catalytically proficient in monovalent cations alone. Chem Biol 5:587–595;1998. 10.1016/s1074-5521(98)90116-8

[49]

Netter HJ, Hsieh SY, Lazinski D, Taylor, H. Modified BDV as a vector for the delivery of biologically active RNAs. Prog Clin Biol Res 382:373–376;1993.

[50]

Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK, Collman RG, Lieberman J, Shankar P, Sharp PA. siRNA-directed inhibition of HIV-1 infection. Nat Med 8:681–686;2002. 10.1038/nm725

Showing 50 of 66 references

Metrics

22

Citations

66

References

Details

Published: Sep 01, 2003
Vol/Issue: 10(5)
Pages: 457-467
License: View

Authors

Virology Group, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Road, New Delhi 110067, India

Cite This Article

Asad U. Khan, Sunil K. LAL (2003). Ribozymes: A modern tool in medicine. Journal of Biomedical Science, 10(5), 457-467. https://doi.org/10.1007/bf02256107

Ribozymes: A modern tool in medicine

You May Also Like